Masimo Corporation  

(Public, NASDAQ:MASI)   Watch this stock  
Find more results for masi
21.65
-0.46 (-2.08%)
May 22 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 21.48 - 22.31
52 week 18.20 - 25.35
Open 22.09
Vol / Avg. 0.00/317,968.00
Mkt cap 1.23B
P/E 19.88
Div/yield 1.00
EPS 1.09
Shares 56.62M
Beta 0.78
Inst. own 81%
Jul 31, 2013
Q2 2013 Masimo Corporation Earnings Release Add to calendar
May 2, 2013
Q1 2013 Masimo Corporation Earnings Conference Call - Webcast
Apr 30, 2013
Q1 2013 Masimo Corporation Earnings Release
Mar 19, 2013
Masimo Corporation at Roth Conference - Webcast
Mar 6, 2013
Masimo Corporation at Raymond James Institutional Investors Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin 12.07% 12.56%
Operating margin 17.02% 17.28%
EBITD margin - 19.18%
Return on average assets 17.23% 16.69%
Return on average equity 23.91% 22.65%
Employees 2,866 -
Carbon Disclosure Rating - -

Address

40 Parker
IRVINE, CA 92618
United States - Map
+1-949-2977000 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Masimo Corporation is a global medical technology company that develops, manufactures, and markets noninvasive patient monitoring products. It develops, manufactures and markets a patient monitoring solution that incorporates a monitor or circuit board and sensors, including single-patient use, reusable and ReSposable sensors and patient cables. In addition, it offers remote alarm/monitoring solutions and software. Its Masimo Signal Extraction Technology (Masimo SET) provides capabilities of Measure-Through Motion and Low Perfusion pulse oximetry to address the primary limitations of conventional pulse oximetry. Masimo SET has been validated in over 100 independent clinical studies. It offers a remote monitoring and clinician notification solution called the Masimo SafetyNet (SafetyNet), which includes its Masimo SET or rainbow SET monitors at the patient�s bedside along with a central assignment station and wired or wireless server. In March 2012, it acquired Spire Semiconductor, LLC.

Officers and directors

Joe E. Kiani Chairman of the Board, Chief Executive Officer
Age: 48
Bio & Compensation  - Reuters
Mark P. de Raad Chief Financial Officer, Executive Vice President, Corporate Secretary
Age: 53
Bio & Compensation  - Reuters
Jon Coleman President - Worldwide Sales, Marketing and Clinical Research
Age: 49
Bio & Compensation  - Reuters
Rick Fishel President - Worldwide OEM Business and Corporate Development
Age: 55
Bio & Compensation  - Reuters
Yongsam Lee Executive Vice President - Operations and Regulatory Affairs, Chief Information Officer
Age: 48
Bio & Compensation  - Reuters
Anand Sampath Executive Vice President - Engineering
Age: 46
Bio & Compensation  - Reuters
Steven J. Barker M.D., Ph.D. Independent Director
Age: 67
Bio & Compensation  - Reuters
Edward L. Cahill Independent Director
Age: 59
Bio & Compensation  - Reuters
Robert L. Coleman Ph.D. Independent Director
Age: 66
Bio & Compensation  - Reuters
Sanford Fitch Independent Director
Age: 71
Bio & Compensation  - Reuters